138 related articles for article (PubMed ID: 29970427)
41. Interphase fluorescence in situ hybridization analysis of CD19-selected cells: Utility in detecting disease in post-therapy samples of B-cell neoplasms.
Parrott AM; Murty VV; Walsh C; Christiano A; Bhagat G; Alobeid B
Cancer Med; 2021 Apr; 10(8):2680-2689. PubMed ID: 33724696
[TBL] [Abstract][Full Text] [Related]
42. Fluorescence In Situ Hybridization (FISH) in Multiple Myeloma.
Tian E
Methods Mol Biol; 2018; 1792():55-69. PubMed ID: 29797252
[TBL] [Abstract][Full Text] [Related]
43. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
[TBL] [Abstract][Full Text] [Related]
44. Interphase cytogenetics of hematological cancer: comparison of classical karyotyping and in situ hybridization using a panel of eleven chromosome specific DNA probes.
Poddighe PJ; Moesker O; Smeets D; Awwad BH; Ramaekers FC; Hopman AH
Cancer Res; 1991 Apr; 51(7):1959-67. PubMed ID: 2004382
[TBL] [Abstract][Full Text] [Related]
45. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
[TBL] [Abstract][Full Text] [Related]
46. Interphase fluorescence in situ hybridization analysis detects a much higher rate of thyroid tumors with clonal cytogenetic deviations of the main cytogenetic subgroups than conventional cytogenetics.
Drieschner N; Rippe V; Laabs A; Dittberner L; Nimzyk R; Junker K; Rommel B; Kiefer Y; Belge G; Bullerdiek J; Sendt W
Cancer Genet; 2011 Jul; 204(7):366-74. PubMed ID: 21872823
[TBL] [Abstract][Full Text] [Related]
47. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
[TBL] [Abstract][Full Text] [Related]
48. Quantity of clonal cells detected by conventional cytogenetic analysis correlates with bone marrow blasts and survival in myelodysplastic syndromes.
Kim M; Chung S; See CJ; Yoon SS; Kim BK; Kim HK; Lee DS
Leuk Res; 2012 Feb; 36(2):163-8. PubMed ID: 21920602
[TBL] [Abstract][Full Text] [Related]
49. [Detection of abnormal numbers of chromosome 8 with interphase fluorescence in situ hybridization in hematologic malignancies].
Wang HP; Li GX; Qiao ZH; Wang HW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):395-7. PubMed ID: 15300644
[TBL] [Abstract][Full Text] [Related]
50. Detection of monosomy 7 in bone marrow by fluorescence in situ hybridization. A study of Fanconi anemia patients and review of the literature.
Thurston VC; Ceperich TM; Vance GH; Heerema NA
Cancer Genet Cytogenet; 1999 Mar; 109(2):154-60. PubMed ID: 10087952
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
52. The success rate of interphase fluorescence in situ hybridization in plasma cell disorders can be improved using unconventional sources of plasma cells.
Panakkal V; Rana S; Rathore S; Anshu A; Balakrishnan A; Singh C; Jandial A; Sachdeva MUS; Varma N; Lad D; Malhotra P; Sreedharanunni S
Int J Lab Hematol; 2022 Feb; 44(1):157-162. PubMed ID: 34636141
[TBL] [Abstract][Full Text] [Related]
53. Dysregulation of Telomere Lengths and Telomerase Activity in Myelodysplastic Syndrome.
Park HS; Choi J; See CJ; Kim JA; Park SN; Im K; Kim SM; Lee DS; Hwang SM
Ann Lab Med; 2017 May; 37(3):195-203. PubMed ID: 28224765
[TBL] [Abstract][Full Text] [Related]
54. Combined cytogenetic testing and fluorescence in situ hybridization analysis in the study of chronic lymphocytic leukemia and multiple myeloma.
Wiktor A; Van Dyke DL
Cancer Genet Cytogenet; 2004 Aug; 153(1):73-6. PubMed ID: 15325099
[TBL] [Abstract][Full Text] [Related]
55. The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies.
Lee DY; Cho HI; Kang YH; Yun SS; Park SY; Lee YS; Kim Y; Lee DS
Cancer Genet Cytogenet; 2004 Jul; 152(1):1-7. PubMed ID: 15193435
[TBL] [Abstract][Full Text] [Related]
56. Comparison of peripheral blood interphase cytogenetics with bone marrow karyotype analysis in myelofibrosis with myeloid metaplasia.
Tefferi A; Meyer RG; Wyatt WA; Dewald GW
Br J Haematol; 2001 Nov; 115(2):316-9. PubMed ID: 11703327
[TBL] [Abstract][Full Text] [Related]
57. Trisomy 12 in B-cell chronic lymphocytic leukemia: interphase study by in situ hybridization in 75 patients.
Coignet L; Berthéas MF; Vasselon C; Jaubert J; Reynaud J; Calmard-Oriol P; Brizard CP; Guyotat D
Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):129-34. PubMed ID: 8332448
[TBL] [Abstract][Full Text] [Related]
58. Detection of RB1 deletions by fluorescence in situ hybridization in malignant hematologic disorders.
Juneau AL; Kaehler M; Christensen ER; Schad CR; Zinsmeister AR; Lust J; Hanson C; Dewald GW
Cancer Genet Cytogenet; 1998 Jun; 103(2):117-23. PubMed ID: 9614909
[TBL] [Abstract][Full Text] [Related]
59. Fluorescent in situ hybridization (FISH) in bone marrow and peripheral blood of leukemia patients: implications for occupational surveillance.
McDevitt MA; Condon M; Stamberg J; Karp JE; McDiarmid M
Mutat Res; 2007 Apr; 629(1):24-31. PubMed ID: 17276720
[TBL] [Abstract][Full Text] [Related]
60. [Fluorescence immunophenotyping and interphase cytogenetics as a tool for the investigation of cytogenetic aberrations of multiple myeloma].
Wang XW; Li JY; Chen LJ; Qian SX; Hong M; Qiao C; Zhang JF; Xu W; Lu H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1316-9. PubMed ID: 19099635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
